Archive · 30 Sep 2025
Lupin to Acquire Eye-Care Firm VISUfarma for €190 Million
Lupin, a big medicine maker, is buying a company called VISUfarma for a lot of money.
VISUfarma makes products for eye health, like those for dry eyes and glaucoma.
This purchase is part of Lupin's plan to grow in Europe and offer more specialized medicines.
VISUfarma sells a lot of different eye care products.
The deal is worth €190 million.
The company has made €48 million in revenue in 2024.
The deal is planned to be done by the end of next year.
Lupin is acquiring VISUfarma for an enterprise value of Euro 190 million.
The acquisition will be conducted by Lupin’s subsidiary, Nanomi B.V.
VISUfarma is a Netherlands-based company specializing in ophthalmology.
VISUfarma has a portfolio of over 60 branded products.
The deal is expected to close by the end of 2025.
- Who
- Lupin, a pharmaceutical company, is acquiring VISUfarma.
- What
- Lupin is acquiring VISUfarma, an eye health company.
- When
- The acquisition is expected to be finalized by the end of 2025.
- Where
- VISUfarma is based in Amsterdam, Netherlands.
- Why
- Lupin aims to expand its European business and strengthen its specialty portfolio.
- Acquisition Target
- VISUfarma B.V.
- Acquiring Company
- Lupin
- Purchase Price
- Euro 190 million
- VISUfarma Revenue (2024)
- €48 million
- VISUfarma Products
- Over 60 branded products
- Closing Date
- Expected by end of 2025